HLA-E and neoplasm: Takahiro Kamiya and colleagues revealed that HLA-E was overexpressed in multiple tumor samples, and anti-NKG2A PEBLs boosted the cytotoxicity of PB-NK cells against tumor cells expressing HLA-E, compared to the anti-NKG2A antibody Z199.